1. Schwartz, T.W.; Rosenkilde, M.M. Is there a 'lock' for all agonist 'keys' in 7TM receptors? Trends Pharmacol Sci. 1996, 17, 213-216.

2. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C.A.; Motoshima, H.; Fox, B.A.; Le Trong, I.; Teller, D.C.; Okada, T.; Stenkamp, R.E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science. 2000, 289, 739-745.

3. Anantharaman, V.; Aravind, L. Application of comparative genomics in the identification and analysis of novel families of membrane-associated receptors in bacteria. BMC Genomics. 2003, 4, 34.

4. Kolakowski, L.F., Jr. GCRDb: a G-protein-coupled receptor database. Receptors Channels. 1994, 2, 1-7.

5. Basler, K.; Christen, B.; Hafen, E. Ligand-independent activation of the sevenless receptor tyrosine kinase changes the fate of cells in the developing Drosophila eye. Cell. 1991, 64, 1069-1081.

6. Willey, K.P. An elusive role for glycosylation in the structure and function of reproductive hormones. Hum. Reprod. Update. 1999, 5, 330-355.

7. Willey, K.P. Structure-Guided Drug Design. D&MD Publications, Westborough, MA, 2004; 500 pp.

8. Fredriksson, R.; Lagerstrom, M.C.; Lundin, L.G, Schioth, H.B. The G-protein coupled receptors in the human genome form five main families: phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol. 2003, 63, 1256-1272.

9. Kauzmann, W. Some factors in the interpretation of protein denaturation. Adv Protein Chem. 1959, 14, 1-63.

10. Phoenix, D.A.; Harris, F.; Daman, O.A.; Wallace, J. The prediction of amphiphilic a-helices. Curr Protein Pept Sci. 2002, 3, 201-221.

11. Okada, T.; Le Trong, I.; Fox, B.A.; Behnke, C.A.; Stenkamp, R.E.; Palczewski, K. X-ray diffraction analysis of three-dimensional crystals of bovine rhodopsin obtained from mixed micelles. J Struct Biol. 2000, 130, 73-80.

12. Iwata, S.; Ostermeier, C.; Ludwig, B.; Michel, H. Structure at 2.8 A resolution of cytochrome C oxidase from Paracoccus denitrificans. Nature. 1995, 376, 660-669.

13. Inooka, H.; Ohtaki, T.; Kitahara, O.; Ikegami, T.; Endo, S.; Kitada, C.; Ogi, K.; Onda, H.; Fujino, M.; Shirakawa, M. Conformation of a peptide ligand bound to its G-protein coupled receptor. Nat Struct Biol. 2001, 8, 161-165.

14. Fu, D.; Libson, A.; Miercke, L.J.; Weitzman, C.; Nollert, P; Krucinski, J.; Stroud, R.M. Structure of a glycerol-conducting channel and the basis for its selectivity. Science. 2000, 290, 481-486.

15. Yamauchi, T.; Kamon, J.; Ito, Y.; Tsuchida, A.; Yokomizo, T.; Kita, S.; Sugiyama, T.; Miyagishi, M.; Hara, K.; Tsunoda, M.; Murakami, K.; Ohteki, T.; Uchida, S.; Takekawa, S.; Waki, H.; Tsuno, N.H.; Shibata, Y.; Terauchi, Y.; Froguel, P; Tobe, K.; Koyasu, S.; Taira, K.; Kitamura, T.; Shimizu, T.; Nagai, R.; Kadowaki, T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003, 423, 762-769.

16. Ballesteros, J. A.; Shi, L.; Javitch, J. A. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol Pharmacol. 2001, 60, 1-19.

17. Lomize, A.L.; Pogozheva, I.D.; Mosberg, H.I. Structural organization of G-protein-coupled receptors. J Comput Aided Mol Des. 1999, 13, 325-353.

18. Meng, E.C.; Bourne, H.R. Receptor activation: what does the rhodopsin structure tell us? Trends Pharmacol Sci. 2001, 22, 587-593.

19. Srinivasan, N.; Sowdhamini, R.; Ramakrishnan, C.; Balaram, P Conformations of disulfide bridges in proteins. Int J Pept Protein Res. 1990, 36, 147-155.

20. Dani, V.S.; Ramakrishnan, C.; Varadarajan, R. MODIP revisited: re-evaluation and refinement of an automated procedure for modeling of disulfide bonds in proteins. Protein Eng. 2003, 16, 187-193.

21. Wang, Y.; Botelho, A.V.; Martinez, G.V.; Brown, M.F. Electrostatic properties of membrane lipids coupled to metarhodopsin II formation in visual transduction. J Am Chem Soc. 2002, 124, 7690-7701.

Bunemann, M.; Frank, M.; Lohse, M. Gi protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc Natl Acad Sci USA. 2003, 100, 16077-16082.

Hunyady, L.; Vauquelin, G.; Vanderheyden, P. Agonist induction and conformational selection during activation of a G-protein-coupled receptor. Trends Pharmacol Sci. 2003, 24, 81-86.

Lipinski, C.A.; Lombardo, F.; Dominy, B.W; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001, 46, 3-26.

Deupi, X.; Olivella, M.; Govaerts, C.; Ballesteros, JA.; Campillo, M.; Pardo, L. Ser and Thr residues modulate the conformation of Pro-kinked transmembrane a-helices. Biophys J. 2004, 86 (1 Pt 1), 105-115.

Bondensgaard, K.; Ankersen, M.; Thogersen, H.; Hansen, B.S.; Wulff, B.S.; Bywater, R.P. Recognition of privileged structures by G-protein coupled receptors. J Med Chem. 2004, 47, 888-899.

Madabushi, S.; Gross, A.K.; Philippi, A.; Meng, E.C.; Wensel, T.G.; Lichtarge, O. Evolutionary trace of G protein-coupled receptors reveals clusters of residues that determine global and class-specific functions. J Biol Chem. 2004, 279, 8126-8132. Suel, G.M.; Lockless, S.W.; Wall, M.A.; Ranganathan, R. Evolutionarily conserved networks of residues mediate allosteric communication in proteins. Nat Struct Biol. 2003, 10, 59-69.

von Korff, M.; Steger, M. GPCR-tailored pharmacophore pattern recognition of small molecular ligands. J Chem Inf Comput Sci. 2004, 44, 1137-1147. Bissantz, C.; Folkers, G.; Rognan, D. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J Med Chem. 2000, 43, 4759-4767.

Bissantz, C.; Bernard, P.; Hibert, M.; Rognan, D. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein coupled receptors suitable targets? Proteins. 2003, 50, 5-25.

Bissantz, C.; Logean, A.; Rognan, D. High-throughput modeling of human G-protein coupled receptors: amino acid sequence alignment, three-dimensional model building, and receptor library screening. J Chem Inf Comput Sci. 2004, 44, 1162-1176. Gouldson, P.R.; Kidley, N.J.; Bywater, R.P.; Psaroudakis, G.; Brooks, H.D.; Diaz, C.; Shire, D.; Reynolds, C.A. Toward the active conformations of rhodopsin and the b2-adrenergic receptor. Proteins. 2004, 56, 67-84.

George, S.R.; O'Dowd, B.F.; Lee, S.P. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov. 2002, 1, 808-820. Zhou, W.; Flanagan, C.; Ballesteros, J.A.; Konvicka, K.; Davidson, J.S.; Weinstein, H.; Millar, R.P.; Sealfon, S.C. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol Pharmacol. 1994, 45, 165-170. Arora, K.K.; Cheng, Z.; Catt, K.J. Dependence of agonist activation on an aromatic moiety in the DPLIY motif of the gonadotropin-releasing hormone receptor. Mol Endocrinol. 1996, 10, 979-986.

Mandiyan, V.; O'Brien, R.; Zhou, M.; Margolis, B.; Lemmon, M.A.; Sturtevant, J.M.; Schlessinger, J. Thermodynamic studies of SHC phosphotyrosine interaction domain recognition of the NPXpY motif. J Biol Chem. 1996, 271, 4770-4775. Abdulaev, N.G.; Ridge, K.D. Light-induced exposure of the cytoplasmic end of transmembrane helix seven in rhodopsin. Proc Natl Acad Sci USA. 1998, 95, 10854-10859.

39. Kalatskaya, I.; Schussler, S.; Blaukat, A.; Muller-Esterl, W.; Jochum, M.; Proud, D.; Faussner, A. Mutation of tyrosine in the conserved NPXXY sequence leads to constitutive phosphorylation and internalization, but not signaling, of the human B2 bradykinin receptor. J Biol Chem. 2004, 279, 31268-31276.

40. Oliveira, L.; Paiva, A.C.; Sander, C.; Vriend, G. A common step for signal transduction in G protein-coupled receptors. Trends Pharmacol Sci. 1994, 15, 170-172.

41. Ballesteros, J.; Kitanovic, S.; Guarnieri, F.; Davies, P.; Fromme, B.J.; Konvicka, K.; Chi L.; Millar, R.P.; Davidson, J.S.; Weinstein, H.; Sealfon, S.C. Functional microdomains in G-protein-coupled receptors: the conserved arginine-cage motif in the gonadotropin-releasing hormone receptor. J Biol Chem. 1998, 273, 10445-10453.

42. Chalmers, D.T.; Behan, D.P. The use of constitutively active GPCRs in drug discovery and functional genomics. Nat Rev Drug Discov. 2002, 1, 599-608.

43. Fanelli, F.; Verhoef-Post, M.; Timmerman, M.; Zeilemaker, A.; Martens, J.W.; Them-men, A.P. Insight into mutation-induced activation of the luteinizing hormone receptor: molecular simulations predict the functional behavior of engineered mutants at M398. Mol Endocrinol. 2004, 18, 1499-1508.

44. Fraser, C.M. Site-directed mutagenesis of b-adrenergic receptors: identification of conserved cysteine residues that independently affect ligand binding and receptor activation. J Biol Chem. 1989, 264, 9266-9270.

45. Giles, G.I.; Jacob, C. Reactive sulfur species: an emerging concept in oxidative stress. Biol Chem. 2002, 383, 375-388.

46. Giles, N.M.; Giles, G.I.; Jacob, C. Multiple roles of cysteine in biocatalysis. Biochem Biophys Res Commun. 2003, 300, 1-4.

47. Willey, K.P; Obermann, H.; Hunt, N.; Henco, K. A universal 2-step method for ligand-induced covalent labelling of cell surface and nuclear receptors by use of the same, single labelling reagent. U.S. Patent 6,156,529, December 5, 2000.

48. Melchiorre, C. Tetramine disulphides: a new tool in a-adrenergic pharmacology. Trends Pharmacol Sci. August 1981, 209-211.

49. Marjamaki, A.; Frang, H.; Pihlavisto, M.; Hoffren, A.M.; Salminen, T.; Johnson, M.S.; Kallio, J.; Javitch, J.A.; Scheinin, M. Chloroethylclonidine and 2-aminoethyl methanethiosulfonate recognize two different conformations of the human a(2A)-adrenergic receptor. J Biol Chem. 1999, 274, 21867-21872.

50. Li, W.; MacDonald, R.G.; Hexum, T.D. Role of sulfhydryl groups in Y2 neuropeptide Y receptor binding activity. J Biol Chem. 1992, 267, 7570-7575.

51. Wong, A.; Hwang, S.M.; Cheng, H.Y.; Crooke, S.T. Structure-activity relationships of b-adrenergic receptor-coupled adenylate cyclase: implications of a redox mechanism for the action of agonists at b-adrenergic receptors. Mol Pharmacol. 1987, 31, 368-376.

52. Malbon, C.C.; George, S.T.; Moxham, C.P. Intramolecular disulphide bridges: avenues to receptor activation? Trends Biochem Sci. 1987, 12, 172-175.

53. Boniface, J.J.; Reichert, L.E Jr. Evidence for a novel thioredoxin-like catalytic property of gonadotropic hormones. Science. 1990, 247, 61-64.

54. Ferreras, M.; Gavilanes, J.G.; Lopez-Otin, C.; Garcia-Segura, J.M. Thiol-disulfide exchange of ribonuclease inhibitor bound to ribonuclease A: evidence of active inhibitor-bound ribonuclease. J Biol Chem. 1995, 270, 28570-28578.

55. Rajarathnam, K.; Sykes, B.D.; Dewald, B.; Baggiolini, M.; Clark-Lewis, I. Disulfide bridges in interleukin-8 probed using non-natural disulfide analogues: dissociation of roles in structure from function. Biochemistry. 1999, 38, 7653-7658.

56. Bertini, R.; Howard, O.M.; Dong, H.F.; Oppenheim, J,J.; Bizzarri, C.; Sergi, R.; Caselli, G.; Pagliei, S.; Romines, B.; Wilshire, J.A.; Mengozzi, M.; Nakamura, H.; Yodoi, J.; Pekkari, K.; Gurunath, R.; Holmgren, A.; Herzenberg, L.A.; Herzenberg, L.A.; Ghezzi, P. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med. 1999, 189, 1783-1789.

57. Hoover, D.M.; Boulegue, C.; Yang, D.; Oppenheim, J.J.; Tucker, K.; Lu, W.; Lubkowski, J. The structure of human macrophage inflammatory protein-3a/CCL20: linking antimicrobial and CC chemokine receptor-6-binding activities with human ß-defensins. J Biol Chem. 2002, 277, 37647-37654.

58. Hilal-Dandan, R.; Villegas, S.; Gonzalez, A.; Brunton, L.L. The quasi-irreversible nature of endothelin binding and G protein-linked signaling in cardiac myocytes. J Pharmacol Exp Ther. 1997, 281, 267-273.

59. Waggoner, W.G.; Genova, S.L.; Rash, V.A. Kinetic analyses demonstrate that the equilibrium assumption does not apply to [125I]-endothelin-1 binding data. Life Sci. 1992, 51, 1869-1876.

60. Spinella, M.J.; Kottke, R.; Magazine, H.I.; Healy, M.S.; Catena, J. A.; Wilken, P; Andersen, T.T. Endothelin-receptor interactions: role of a putative sulfhydryl on the endothelin receptor. FEBS Lett. 1993, 328, 82-88.

61. Morgan, R.S.; Tatsch, C.E.; Gushard, R.H.; McAdon, J.; Warme, P.K. Chains of alternating sulfur and p-bonded atoms in eight small proteins. Int J Pept Protein Res. 1978, 11, 209-217.

62. Meyer, E.A.; Castellano, R.K.; Diederich, F. Interactions with aromatic rings in chemical and biological recognition. Angew Chem Int Ed Engl. 2003, 42, 1210-1250.

63. Zacharias, N.; Dougherty, D.A. Cation-p interactions in ligand recognition and catalysis. Trends Pharmacol Sci. 2002, 23, 281-287.

64. Brandt, W.; Golbraikh, A.; Tager, M.; Lendeckel, U. A molecular mechanism for the cleavage of a disulfide bond as the primary function of agonist binding to G-protein-coupled receptors based on theoretical calculations supported by experiments. Eur J Biochem. 1999, 261, 89-97.

65. Garcia-Higuera, I.; Thomas, T.C.; Yi, F.; Neer, E.J. Intersubunit surfaces in G protein aßg heterotrimers: analysis by cross-linking and mutagenesis of ßg J Biol Chem. 1996, 271, 528-535.


67. Onuffer, J.J.; Horuk, R. Chemokines, chemokine receptors and small-molecule antagonists: recent developments. Trends Pharmacol Sci. 2002, 23 (10), 459-467.

68. Müller, G. Medicinal chemistry of target family-directed masterkeys. Drug Discov Today. 2003, 8, 681-691.

69. Malnic, B.; Hirono, J.; Sato, T.; Buck, L.B. Combinatorial receptor codes for odors. Cell. 1999, 96, 713-723.

Diabetes Sustenance

Diabetes Sustenance

Get All The Support And Guidance You Need To Be A Success At Dealing With Diabetes The Healthy Way. This Book Is One Of The Most Valuable Resources In The World When It Comes To Learning How Nutritional Supplements Can Control Sugar Levels.

Get My Free Ebook

Post a comment